Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
(2014) In BMC Urology 14(1).- Abstract
- Reduced membranous expression of the cytoskeleton-associated protein ezrin has previously been demonstrated to correlate with tumour progression and poor prognosis in patients with T1G3 urothelial cell carcinoma of the bladder treated with non-maintenance Bacillus Calmette-Guérin (n = 92), and the associations with adverse clinicopathological factors have been validated in another, unselected, cohort (n = 104). In the present study, we examined the prognostic significance of ezrin expression in urothelial bladder cancer in a total number of 442 tumours from two independent patient cohorts.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4529533
- author
- Andersson, Gustav
LU
; Wennersten, Christoffer
; Gaber, Alexander
LU
; Boman, Karolina
LU
; Nodin, Björn
LU
; Uhlén, Mathias
; Segersten, Ulrika
; Malmström, Per
and Jirström, Karin
LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMC Urology
- volume
- 14
- issue
- 1
- article number
- 36
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:24885195
- wos:000337474600001
- scopus:84902284556
- pmid:24885195
- ISSN
- 1471-2490
- DOI
- 10.1186/1471-2490-14-36
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Oncology, MV (013035000), Pathology, (Lund) (013030000)
- id
- 08431305-4761-464c-89bc-287cd1209fb2 (old id 4529533)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24885195?dopt=Abstract
- date added to LUP
- 2016-04-01 14:03:03
- date last changed
- 2024-01-29 02:52:21
@article{08431305-4761-464c-89bc-287cd1209fb2, abstract = {{Reduced membranous expression of the cytoskeleton-associated protein ezrin has previously been demonstrated to correlate with tumour progression and poor prognosis in patients with T1G3 urothelial cell carcinoma of the bladder treated with non-maintenance Bacillus Calmette-Guérin (n = 92), and the associations with adverse clinicopathological factors have been validated in another, unselected, cohort (n = 104). In the present study, we examined the prognostic significance of ezrin expression in urothelial bladder cancer in a total number of 442 tumours from two independent patient cohorts.}}, author = {{Andersson, Gustav and Wennersten, Christoffer and Gaber, Alexander and Boman, Karolina and Nodin, Björn and Uhlén, Mathias and Segersten, Ulrika and Malmström, Per and Jirström, Karin}}, issn = {{1471-2490}}, language = {{eng}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{BMC Urology}}, title = {{Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.}}, url = {{https://lup.lub.lu.se/search/files/3743906/5147882}}, doi = {{10.1186/1471-2490-14-36}}, volume = {{14}}, year = {{2014}}, }